Patent · US Active

Triazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases

US7977352B2 · kind B2 · utility

0Cited by

2References

32Claims

0Family size

Assignee

Galapagos NV · BE

Inventors

Paul Edwards · Sandwich, GB
Wolfgang Schmidt · Frankfurt, DE
Veronique Birault · Hertford, GB
Friedrich Kroll · Schneverdingen, DE
Andrew Burritt · San Diego, US
Xueliang Tao · Arlington, US
Martin James Inglis Andrews · Mechelen, BE
Sébastien Laurent Xavier Martina · Mechelen, BE

Key dates

Filing date	Nov 30, 2007
Grant date	Jul 12, 2011
Priority date	—
Expiry date	Nov 30, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel triazolopyridine compounds are disclosed that have a formula represented by the following:The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, ECM degradation, joint degradation and/or inflammation, and others.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.